Monopar Therapeutics
MNPR
#8739
Rank
S$0.14 B
Marketcap
$26.54
Share price
3.74%
Change (1 day)
1,240.59%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2023 (TTM): -$1.05

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.04. In 2022 the company made an earnings per share (EPS) of -$1.12 a decrease over its 2021 EPS that were of -$1.00.

EPS history for Monopar Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.05-6.09%
2022-$1.1212.16%
2021-$1.0027.59%
2020-$0.7843.71%
2019-$0.5433.52%
2018-$0.41-80.97%
2017-$2.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.94 183.12%๐Ÿ‡บ๐Ÿ‡ธ USA